These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8022060)

  • 1. Torsades de pointes in paced patients with sick sinus syndrome after disopyramide administration.
    Kimura Y; Takayanagi K; Sakai Y; Satoh T; Fujito T; Inoue T; Hayashi T; Morooka S; Takabatake Y
    Jpn Heart J; 1994 Mar; 35(2):153-61. PubMed ID: 8022060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of sick sinus syndrome that developed torsades de pointes, pacing failure and sensing failure during administration of bepridil.
    Ohsawa M; Tanaka F; Kunugita F; Saito H; Nakamura M; Shiroto T; Hotta K; Chiba N; Hiramori K
    Jpn Heart J; 2003 Sep; 44(5):783-8. PubMed ID: 14587660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.
    Ohki R; Takahashi M; Mizuno O; Fujikawa H; Mitsuhashi T; Katsuki T; Ikeda U; Shimada K
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):119-21. PubMed ID: 11227957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Torsades de pointes ventricular tachycardia induced by disopyramide at therapeutic serum concentration].
    Aarskog D; Reikvam A
    Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2511-3. PubMed ID: 1412257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of VVI pacing on atrial and ventricular function in patients with sick sinus syndrome.
    Paxinos G; Katritsis D; Kakouros S; Toutouzas P; Camm AJ
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):728-34. PubMed ID: 9584304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome.
    Strickberger SA; Fish RD; Lamas GA; Cantillon C; Bhatia S; McGowan N; Antman EM; Friedman PL
    Am J Cardiol; 1993 Jan; 71(1):53-6. PubMed ID: 8420236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers.
    Pinski SL; Eguía LE; Trohman RG
    Pacing Clin Electrophysiol; 2002 Nov; 25(11):1612-5. PubMed ID: 12494620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Suyama K; Aihara N; Takaki H; Kamakura S; Shimomura K
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):695-705. PubMed ID: 9080496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between bradycardia dependent long QT syndrome and QT prolongation by disopyramide in humans.
    Furushima H; Niwano S; Chinushi M; Ohhira K; Abe A; Aizawa Y
    Heart; 1998 Jan; 79(1):56-8. PubMed ID: 9505920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
    Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Images in cardiology. Pacemaker induced torsades de pointes tachycardia.
    Böhm A; Pintér A; Préda I
    Heart; 1998 Nov; 80(5):466. PubMed ID: 9930045
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of dual chamber pacing in sick sinus syndrome.
    Mitsuoka T; Kenny RA; Yeung TA; Chan SL; Perrins JE; Sutton R
    Br Heart J; 1988 Oct; 60(4):338-47. PubMed ID: 3056477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Torsades de pointes initiated by slow ventricular stimulation].
    Fontaine G; Frank R; Lascault G; Tonet JL; Fillette F; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):918-24. PubMed ID: 6414425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate.
    Anzawa R; Ishikawa S; Tanaka Y; Okazaki F; Mochizuki S
    J Interv Card Electrophysiol; 2005 Jun; 13(1):51-3. PubMed ID: 15976979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disopyramide-induced Torsade de Pointes.
    Tzivoni D; Keren A; Stern S; Gottlieb S
    Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe respiratory failure and torsades de pointes induced by disopyramide in a patient with myasthenia gravis.
    Hirose K; Yamaguchi H; Oshima Y; Choraku M; Hirono A; Takamori N; Tamura K
    Intern Med; 2008; 47(19):1703-8. PubMed ID: 18827420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life.
    Lau CP; Tai YT; Leung WH; Wong CK; Lee P; Chung FL
    Eur Heart J; 1994 Nov; 15(11):1445-55. PubMed ID: 7835358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.